Markets & Regulations

Diamond Pharma Services acquires PharmaCentral

12-May-2020 By Jenni Spinner

The purchase of the Irish pharmacovigilance specialist is intended to expand’s Diamond’s European presence, and increase its senior-level industry expertise.

Weekly FDA COVID-19 update

07-May-2020 By Jenni Spinner

The agency continues to remain busy overseeing and approving potential treatments and tests for the virus behind the global pandemic.

People on the Move: May 2020

06-May-2020 By Jenni Spinner

This month’s new hires and promotions include executive appointments at Advarra, Eversana, Signant Health, Endpoint Clinical and other companies.

This week’s FDA COVID-19 news

30-Apr-2020 By Jenni Spinner

The agency continues to offer guidance about COVID-19 treatments and tests—and issue warnings to companies that fall out of line.

Novartis acquires digital therapeutics specialist Amblyotech

28-Apr-2020 By Jenni Spinner

The pharmaceutical firm has purchased the company, which specializes in advancing treatments and diagnostics for ocular disorders.

FDA update on COVID-19 actions and advisements

23-Apr-2020 By Jenni Spinner

Over the past week, the agency has issued guidances, taken action to accelerate treatments and put a stop to fraudulent treatments for the pandemic-causing virus.

FDA COVID-19 roundup: actions and advisories

15-Apr-2020 By Jenni Spinner

The federal agency has issued several guidances, provided updates and taken actions related to the global pandemic over the past seven days.

FDA COVID-19 response roundup

08-Apr-2020 By Jenni Spinner

The federal agency continues to take action and make announcements centered on nationwide efforts to combat the virus causing the global pandemic.

FDA requests recall of ranitidine drug products

02-Apr-2020 By Jenni Spinner

The agency is asking manufacturers to withdraw all products containing ranitidine due to contamination concerns around a possible carcinogen.

FDA updates and actions on COVID-19

01-Apr-2020 By Jenni Spinner

The federal agency has announced a slew of legislation, advisory statements and other items impacting the US in the face of the pandemic.

Gilead rescinds request for remdesivir orphan status

30-Mar-2020 By Jenni Spinner

The pharmaceutical company has withdrawn its orphan designation request for its antiviral for the treatment of COVID-19.

FDA grants chloroquine emergency authorization as coronavirus treatment

30-Mar-2020 By Vassia Barba

The US FDA has issued the first emergency use authorization to chloroquine phosphate and hydroxychloroquine sulfate as treatments against coronavirus.